Open-label extension study of the efficacy and safety of rufinamide adjunctive therapy in patients with Lennox-Gastaut syndrome

被引：0
|
作者：
Glauser, T
Kluger, G
Sachdeo, R
Krauss, G
Perdomo, C
Arroyo, S
机构：
[1] Cincinnati Childrens Hosp, Cincinnati, OH USA
[2] BHZ, Vogtareuth, Germany
[3] St Peters Univ Hosp, New Brunswick, NJ USA
[4] Johns Hopkins Med Ctr, Baltimore, MD USA
[5] Eisai Med Res, Ridgefield Pk, NJ USA
来源：
EPILEPSIA | 2005年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：408 / 408
页数：1
相关论文
共 50 条
  • [31] Long-term safety and efficacy of add-on cannabidiol in patients with Lennox-Gastaut syndrome: Results of a long-term open-label extension trial
    Patel, Anup D.
    Mazurkiewicz-Beldzinska, Maria
    Chin, Richard F.
    Gil-Nagel, Antonio
    Gunning, Boudewijn
    Halford, Jonathan J.
    Mitchell, Wendy
    Scott Perry, Michael
    Thiele, Elizabeth A.
    Weinstock, Arie
    Dunayevich, Eduardo
    Checketts, Daniel
    Devinsky, Orrin
    EPILEPSIA, 2021, 62 (09) : 2228 - 2239
  • [32] RUFINAMIDE IN CHILDREN WITH LENNOX-GASTAUT SYNDROME AND OTHER RELATED REFRACTORY EPILEPTIC ENCEPHALOPATHIES: A PROSPECTIVE, ADD-ON, OPEN-LABEL TREATMENT STUDY
    Cantarin, V.
    Garcia-Penas, J.
    Ruiz-Falco, M.
    Lara-Herguedas, J.
    Duat-Rodriguez, A.
    Lopez-Marin, L.
    Gutierrez-Solana, L.
    Rodrigo, M.
    Gutierrez, N.
    Perez-Jimenez, M.
    EPILEPSIA, 2009, 50 : 149 - 149
  • [33] Maintained Safety and Efficacy of Cannabidiol in a Long-Term Open-Label Trial in Patients with Lennox-Gastaut Syndrome (GWPCARE5)
    Marsh, E.
    Mazurkiewicz-Beldzinska, M.
    Halford, J.
    Gunning, B.
    Checketts, D.
    Roberts, C.
    Thiele, E.
    EPILEPSIA, 2018, 59 : S9 - S9
  • [34] A COMPARISON OF COST EFFECTIVENESS OF RUFINAMIDE WITH LAMOTRIGINE AND TOPIRAMATE IN THE ADJUNCTIVE TREATMENT OF LENNOX-GASTAUT SYNDROME
    Yeates, Andrew
    Verdian, Lara
    Yi, Y.
    Jansen, J.
    EPILEPSIA, 2008, 49 : 96 - 96
  • [35] Effect of Rufinamide to Patients with Intractable Epilepsy besides Lennox-Gastaut Syndrome
    Ishihara, N.
    Hibino, H.
    Ishimaru, S.
    Miyake, M.
    EPILEPSIA, 2018, 59 : S73 - S73
  • [36] Rufinamide efficacy and safety in children aged 1-4 years with Lennox-Gastaut syndrome
    Kim, Shin Hye
    Kang, Hoon-Chul
    Lee, Joon Soo
    Kim, Heung Dong
    BRAIN & DEVELOPMENT, 2018, 40 (10): : 897 - 903
  • [37] Topiramate in Lennox-Gastaut syndrome: Open-label treatment of patients completing a randomized controlled trial
    Glauser, TA
    Levisohn, PM
    Ritter, F
    Sachdeo, RC
    EPILEPSIA, 2000, 41 : S86 - S90
  • [38] Efficacy of Rufinamide as Adjunctive Treatment for Adults With Lennox-Gastaut Syndrome: Subgroup Analysis From a Phase III Trial
    Striano, Pasquale
    McMurray, Rob
    NEUROLOGY, 2016, 86
  • [39] Efficacy of Rufinamide as Adjunctive Treatment for Adults With Lennox-Gastaut Syndrome: Subgroup Analysis From a Phase III Trial
    Striano, Pasquale
    McMurray, Rob
    NEUROLOGY, 2016, 86
  • [40] Cognitive, adaptive, and behavioral effects of adjunctive rufinamide in Lennox-Gastaut syndrome: A prospective observational clinical study
    Operto, Francesca Felicia
    Verrotti, Alberto
    Marrelli, Alfonso
    Ciuffini, Roberta
    Coppola, Giangennaro
    Pastorino, Grazia Maria Giovanna
    Striano, Pasquale
    Sole, Michela
    Zucca, Claudio
    Manfredi, Valentina
    Citta, Santina
    Elia, Maurizio
    EPILEPSY & BEHAVIOR, 2020, 112
12345